ASVD Underlying Cause
In response to the injury, inflammation occurs, which causes further damage to the inside wall of the artery. Cholesterol is deposited at the site of the injury and the cholesterol is covered by a layer of scar tissue. The scar tissue is produced by the cells that make up the wall of the artery.
The combination of cholesterol and scar tissue is called a plaque. The plaque may continue to grow on the inside of the vessel, reducing the space for blood to flow through the vessel. The plaque may also break away from the wall of the blood vessel, where it is carried further in the artery by the bloodstream. As the artery becomes smaller and smaller, eventually the plaque becomes stuck in the artery. This completely stops blood from flowing to the tissues supplied by the artery.
Atherosclerosis can cause:
The amino acid, homocysteine, plays a role in atherosclerosis.
Homocysteine may cause atherosclerosis by damaging the lining of arteries. High blood levels of homocysteine are related to a higher risk of heart disease, stroke and peripheral vascular disease.
Inflammation plays a major role in the progression of atherosclerosis. Although cholesterol is a major component of the plaque, inflammation of the damaged artery leads to the formation of the plaque.
Higher blood levels of the chemicals produced by the inflammation are related to a higher risk of heart disease, stroke and peripheral vascular disease.
Continue to ASVD Anatomy
- Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis. 2003 Jul-Aug;46(1):11-29. 
- de Leeuw K, Kallenberg C, Bijl M. Accelerated atherosclerosis in patients with systemic autoimmune diseases. Ann N Y Acad Sci. 2005 Jun;1051:362-71. 
- Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005 Apr 21;352(16):1685-95. 
- Lederle FA, Nelson DB, Joseph AM. Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg. 2003 Aug;38(2):329-34. 
- Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005 Jun 28;111(25):3481-8. 
- Standridge JB. Hypertension and atherosclerosis: clinical implications from the ALLHAT Trial. Curr Atheroscler Rep. 2005 Mar;7(2):132-9. 
- Tiong AY, Brieger D. Inflammation and coronary artery disease. Am Heart J. 2005 Jul;150(1):11-8.